GLYMTOP-M3 TAB is a combination of Glimepiride and Metformin, used in the treatment of type 2 diabetes mellitus in adults. It is prescribed when diet and regular exercise alone are not sufficient to achieve optimal blood glucose control. Glimepiride helps lower blood sugar levels by stimulating insulin release from the pancreas, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, they help maintain stable blood glucose levels and support effective diabetes management.
Glimepiride improves insulin secretion to lower blood glucose levels, while Metformin 500 mg reduces hepatic glucose production and enhances insulin sensitivity, together providing balanced glycemic control.
Improves Blood Glucose Control: Helps maintain healthy blood sugar levels throughout the day.
Dual-Mechanism Action: Combines insulin secretion support with improved insulin sensitivity.
Supports Long-Term Diabetes Management: Reduces the risk of diabetes-related complications.
Effective Alongside Diet and Exercise: Enhances overall diabetes control when combined with lifestyle management.
Clinically Trusted Combination Therapy: Widely prescribed under medical supervision.
Take the tablet exactly as prescribed by a healthcare professional, preferably with meals. Regular monitoring of blood glucose levels is recommended.
May include low blood sugar, nausea, stomach upset, dizziness, or headache. Consult a healthcare provider if side effects persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Glimepiride & Metformin Tablets IP (500 mg) sourced from reputed pharmaceutical manufacturers. GLYMTOP-M3 TAB is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.